nach oben

Journal of Neurology

Erschienen in:

06.01.2018 | Original Communication

Does early postoperative drug regimen impact seizure control in patients undergoing temporal lobe resections?

verfasst von: Barbara Schmeiser, Bernhard J. Steinhoff, Andreas Schulze-Bonhage

Erschienen in: Journal of Neurology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Objective

To evaluate the impact of postoperative antiepileptic drug (AED) load on seizure control in patients who underwent surgical treatment for pharmacoresistant mesiotemporal lobe epilepsy during the first two postoperative years.

Patients and methods

532 consecutive patients (48.7% males and 51.7% females) who underwent surgical treatment for mesiotemporal lobe epilepsy were retrospectively evaluated regarding effects of AED load on seizures control during the first 2 years following epilepsy surgery. We analyzed whether postoperative increases in postoperative AED load are associated with better seizure control in patients initially not seizure free, and if postoperative decreases in postoperative AED load would increase the risk for seizure persistence or recurrence. For statistical analyses, Fisher’s exact and Wilcoxon test were applied.

Results

68.9, 64.0 and 59.1% of patients were completely seizure free (Engel Ia) at 3, 12 and 24 months after surgery, respectively. Patients in whom daily drug doses were increased did not have a higher rate of seizure freedom at any of the three follow-up periods. Of 16 patients achieving secondary seizure control at 12 months after surgery, only one did so with an increase in drug load in contrast to 15 patients who experienced a running down of seizures independent of drug load increases. Decreases in drug load did not significantly increase the risk for seizure recurrence. Of postoperatively seizure free patients at 3 months after surgery in whom AED were consequently reduced, 85% remained completely seizure free at 1 year and 76% at 1 year after surgery, respectively, as opposed to 86% each when AED was not reduced (differences n.s.). Mean daily drug load was significantly lower in seizure free patients at 12 and 24 months compared to patients with ongoing seizures.

Conclusion

In this large patient cohort stratified to the epilepsy syndrome neither did a postoperative reduction in drug load significantly increase the risk for seizure relapse nor did increases in drug dosages lead to improved seizure control. Mean drug load was on average lower in seizure free- than non-seizure free patients at 12 and 24 months of follow-up. Secondary seizure control after initial postoperative seizures in > 90% of cases occurred as a running down, independent of an AED increase. Thus, the effect of the surgical intervention rather than the postoperative drug regimen was the key determinant for seizure control. This finding supports a curative role of temporal lobe surgery rather than an effect rendering the majority of patients’ pharmacoresponsive with a critical role of the antiepileptic drug regime for seizure control.

Wiebe S, Blume WT, Girvin JP et al (2001) A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 345:311–318. https://doi.org/10.1056/NEJM200108023450501 CrossRefPubMed

McIntosh AM, Wilson SJ, Berkovic SF (2001) Seizure outcome after temporal lobectomy: current research practice and findings. Epilepsia 42:1288–1307CrossRefPubMed

Engel J (1993) Clinical neurophysiology, neuroimaging, and the surgical treatment of epilepsy. Curr Opin Neurol Neurosurg 6:240–249PubMed

Fauser S, Schulze-Bonhage A (2015) In response: long-term seizure outcome in 211 patients with focal cortical dysplasia. Epilepsia 56:1177–1178. https://doi.org/10.1111/epi.13017 CrossRefPubMed

Tellez-Zenteno JF, Dhar R, Hernandez-Ronquillo L, Wiebe S (2007) Long-term outcomes in epilepsy surgery: antiepileptic drugs, mortality, cognitive and psychosocial aspects. Brain 130:334–345. https://doi.org/10.1093/brain/awl316 CrossRefPubMed

Seiam AH, Dhaliwal H, Wiebe S (2011) Determinants of quality of life after epilepsy surgery: systematic review and evidence summary. Epilepsy Behav 21:441–445. https://doi.org/10.1016/j.yebeh.2011.05.005 CrossRefPubMed

Taylor DC, McMacKin D, Staunton H et al (2001) Patients’ aims for epilepsy surgery: desires beyond seizure freedom. Epilepsia 42:629–633CrossRefPubMed

Berg AT, Langfitt JT, Spencer SS, Vickrey BG (2007) Stopping antiepileptic drugs after epilepsy surgery: a survey of U.S. epilepsy center neurologists. Epilepsy Behav 10:219–222. https://doi.org/10.1016/j.yebeh.2006.12.001 CrossRefPubMedPubMedCentral

Tellez-Zenteno JF, Ronquillo LH, Jette N et al (2012) Discontinuation of antiepileptic drugs after successful epilepsy surgery. A Canadian survey. Epilepsy Res 102:23–33. https://doi.org/10.1016/j.eplepsyres.2012.04.018 CrossRefPubMed

10.

Hoppe C, Poepel A, Sassen R, Elger CE (2006) Discontinuation of anticonvulsant medication after epilepsy surgery in children. Epilepsia 47:580–583. https://doi.org/10.1111/j.1528-1167.2006.00471.x CrossRefPubMed

11.

Helmstaedter C, Elger CE, Witt JA (2016) The effect of quantitative and qualitative antiepileptic drug changes on cognitive recovery after epilepsy surgery. Seizure 36:63–69. https://doi.org/10.1016/j.seizure.2016.02.001 CrossRefPubMed

12.

Aldenkamp AP, Alpherts WC, Sandstedt P et al (1998) Antiepileptic drug-related cognitive complaints in seizure-free children with epilepsy before and after drug discontinuation. Epilepsia 39:1070–1074CrossRefPubMed

13.

Cramer JA, Mintzer S, Wheless J, Mattson RH (2010) Adverse effects of antiepileptic drugs: a brief overview of important issues. Expert Rev Neurother 10:885–891. https://doi.org/10.1586/ern.10.71 CrossRefPubMed

14.

Langfitt JT, Holloway RG, McDermott MP et al (2007) Health care costs decline after successful epilepsy surgery. Neurology 68:1290–1298. https://doi.org/10.1212/01.wnl.0000259550.87773.3d CrossRefPubMed

15.

Cole AJ, Wiebe S (2008) Debate: should antiepileptic drugs be stopped after successful epilepsy surgery? Epilepsia 49(Suppl 9):29–34. https://doi.org/10.1111/j.1528-1167.2008.01924.x CrossRefPubMed

16.

McIntosh AM, Kalnins RM, Mitchell LA et al (2004) Temporal lobectomy: long-term seizure outcome, late recurrence and risks for seizure recurrence. Brain 127:2018–2030. https://doi.org/10.1093/brain/awh221 CrossRefPubMed

17.

Spencer SS, Berg AT, Vickrey BG et al (2005) Predicting long-term seizure outcome after resective epilepsy surgery: the multicenter study. Neurology 65:912–918. https://doi.org/10.1212/01.wnl.0000176055.45774.71 CrossRefPubMed

18.

Yardi R, Irwin A, Kayyali H et al (2014) Reducing versus stopping antiepileptic medications after temporal lobe surgery. Ann Clin Transl Neurol 1:115–123. https://doi.org/10.1002/acn3.35 CrossRefPubMedPubMedCentral

19.

Lossius MI, Hessen E, Mowinckel P et al (2008) Consequences of antiepileptic drug withdrawal: a randomized, double-blind study (Akershus Study). Epilepsia 49:455–463. https://doi.org/10.1111/j.1528-1167.2007.01323.x CrossRefPubMed

20.

Kim YD, Heo K, Park SC et al (2005) Antiepileptic drug withdrawal after successful surgery for intractable temporal lobe epilepsy. Epilepsia 46:251–257. https://doi.org/10.1111/j.0013-9580.2005.28004.x CrossRefPubMed

21.

Pimentel J, Peralta AR, Campos A et al (2012) Antiepileptic drugs management and long-term seizure outcome in post surgical mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsy Res 100:55–58. https://doi.org/10.1016/j.eplepsyres.2012.01.010 CrossRefPubMed

22.

Berg AT, Vickrey BG, Langfitt JT et al (2006) Reduction of AEDs in postsurgical patients who attain remission. Epilepsia 47:64–71. https://doi.org/10.1111/j.1528-1167.2006.00371.x CrossRefPubMed

23.

Lachhwani DK, Loddenkemper T, Holland KD et al (2008) Discontinuation of medications after successful epilepsy surgery in children. Pediatr Neurol 38:340–344. https://doi.org/10.1016/j.pediatrneurol.2008.01.010 CrossRefPubMed

24.

Schmidt D, Loscher W (2003) How effective is surgery to cure seizures in drug-resistant temporal lobe epilepsy? Epilepsy Res 56:85–91CrossRefPubMed

25.

Schiller Y, Cascino GD, So EL, Marsh WR (2000) Discontinuation of antiepileptic drugs after successful epilepsy surgery. Neurology 54:346–349CrossRefPubMed

26.

Al-Kaylani M, Konrad P, Lazenby B et al (2007) Seizure freedom off antiepileptic drugs after temporal lobe epilepsy surgery. Seizure 16:95–98. https://doi.org/10.1016/j.seizure.2006.10.007 CrossRefPubMed

27.

Kwan P, Arzimanoglou A, Berg AT et al (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 51:1069–1077. https://doi.org/10.1111/j.1528-1167.2009.02397.x CrossRefPubMed

28.

Engel JJ, Van Nes PC, Rasmussen TB, Ojemann LM (1993) Outcome with respect to epileptic seizures in surgical treatment of the epilepsies. N Y Raven Press, New York, pp 609–621

29.

WHO (2015) WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment

30.

Schmidt D, Baumgartner C, Loscher W (2004) The chance of cure following surgery for drug-resistant temporal lobe epilepsy. What do we know and do we need to revise our expectations? Epilepsy Res 60:187–201. https://doi.org/10.1016/j.eplepsyres.2004.07.004 PubMed

31.

Salanova V, Andermann F, Rasmussen T et al (1996) The running down phenomenon in temporal lobe epilepsy. Brain 119(Pt 3):989–996CrossRefPubMed

32.

Ladino LD, Hernandez-Ronquillo L, Tellez-Zenteno JF (2014) Management of antiepileptic drugs following epilepsy surgery: a meta-analysis. Epilepsy Res 108:765–774. https://doi.org/10.1016/j.eplepsyres.2014.01.024 CrossRefPubMed

33.

Kuzniecky R, Rubin ZK, Faught E, Morawetz R (1992) Antiepileptic drug treatment after temporal lobe epilepsy surgery: a randomized study comparing carbamazepine and polytherapy. Epilepsia 33:908–912CrossRefPubMed

34.

Griffin CT, Abastillas ME, Armon C et al (2004) Early antiepileptic drug reduction following anterior temporal lobectomy for medically intractable complex partial epilepsy. Seizure 13:434–437. https://doi.org/10.1016/j.seizure.2003.10.004 CrossRefPubMed

35.

Tanriverdi T, Ajlan A, Poulin N, Olivier A (2009) Morbidity in epilepsy surgery: an experience based on 2449 epilepsy surgery procedures from a single institution. J Neurosurg 110:1111–1123. https://doi.org/10.3171/2009.8.JNS08338 CrossRefPubMed

36.

Kerling F, Pauli E, Lorber B et al (2009) Drug withdrawal after successful epilepsy surgery: how safe is it? Epilepsy Behav 15:476–480. https://doi.org/10.1016/j.yebeh.2009.05.016 CrossRefPubMed

37.

Boshuisen K, Braams O, Jennekens-Schinkel A et al (2009) Medication policy after epilepsy surgery. Pediatr Neurol 41:332–338. https://doi.org/10.1016/j.pediatrneurol.2009.04.025 CrossRefPubMed

38.

Park KI, Lee SK, Chu K et al (2010) Withdrawal of antiepileptic drugs after neocortical epilepsy surgery. Ann Neurol 67:230–238. https://doi.org/10.1002/ana.21884 CrossRefPubMed

39.

Rathore C, Sarma SP, Radhakrishnan K (2011) Prognostic importance of serial postoperative EEGs after anterior temporal lobectomy. Neurology 76:1925–1931. https://doi.org/10.1212/WNL.0b013e31821d74b3 CrossRefPubMed

40.

Das RR, Artsy E, Hurwitz S et al (2012) Outcomes after discontinuation of antiepileptic drugs after surgery in patients with low grade brain tumors and meningiomas. J Neurooncol 107:565–570. https://doi.org/10.1007/s11060-011-0779-y CrossRefPubMed

41.

Menon R, Rathore C, Sarma SP, Radhakrishnan K (2012) Feasibility of antiepileptic drug withdrawal following extratemporal resective epilepsy surgery. Neurology 79:770–776. https://doi.org/10.1212/WNL.0b013e3182644f7d CrossRefPubMed

42.

Tanriverdi T, Olivier A, Poulin N et al (2008) Long-term seizure outcome after mesial temporal lobe epilepsy surgery: corticalamygdalohippocampectomy versus selective amygdalohippocampectomy. J Neurosurg 108:517–524. https://doi.org/10.3171/JNS/2008/108/3/0517 CrossRefPubMed

43.

Malmgren K, Edelvik A (2017) Long-term outcomes of surgical treatment for epilepsy in adults with regard to seizures, antiepileptic drug treatment and employment. Seizure 44:217–224. https://doi.org/10.1016/j.seizure.2016.10.015 CrossRefPubMed

44.

Reinholdson J, Olsson I, Edelvik A et al (2015) Long-term follow-up after epilepsy surgery in infancy and early childhood—a prospective population based observational study. Seizure 30:83–89. https://doi.org/10.1016/j.seizure.2015.05.019 CrossRefPubMed

45.

Braathen G, Melander H (1997) Early discontinuation of treatment in children with uncomplicated epilepsy: a prospective study with a model for prediction of outcome. Epilepsia 38:561–569CrossRefPubMed

46.

Verrotti A, Morresi S, Basciani F et al (2000) Discontinuation of anticonvulsant therapy in children with partial epilepsy. Neurology 55:1393–1395CrossRefPubMed

47.

Peters AC, Brouwer OF, Geerts AT et al (1998) Randomized prospective study of early discontinuation of antiepileptic drugs in children with epilepsy. Neurology 50:724–730CrossRefPubMed

48.

Zeng TF, An DM, Li JM et al (2012) Evaluation of different antiepileptic drug strategies in medically refractory epilepsy patients following epilepsy surgery. Epilepsy Res 101:14–21. https://doi.org/10.1016/j.eplepsyres.2012.02.013 CrossRefPubMed

49.

Helmstaedter C, Witt JA (2017) How neuropsychology can improve the care of individual patients with epilepsy. Looking back and into the future. Seizure 44:113–120. https://doi.org/10.1016/j.seizure.2016.09.010 CrossRefPubMed

50.

Uijl SG, Leijten FS, Arends JB et al (2008) Prognosis after temporal lobe epilepsy surgery: the value of combining predictors. Epilepsia 49:1317–1323. https://doi.org/10.1111/j.1528-1167.2008.01695.x CrossRefPubMed

51.

Spencer SS, Spencer DD, Williamson PD, Mattson RH (1981) Ictal effects of anticonvulsant medication withdrawal in epileptic patients. Epilepsia 22:297–307CrossRefPubMed

52.

Schmidt D, Baumgartner C, Loscher W (2004) Seizure recurrence after planned discontinuation of antiepileptic drugs in seizure-free patients after epilepsy surgery: a review of current clinical experience. Epilepsia 45:179–186CrossRefPubMed

53.

van Veelen CW, van Rijen PC, Debets RM et al (2001) Dutch Collaborative Epilepsy Surgery Program: reduction of seizures, operative complications and tapering of medication in 338 patients, 1973–1998. Ned Tijdschr Geneeskd 145:2223–2228PubMed

54.

Boshuisen K, Arzimanoglou A, Cross JH et al (2012) Timing of antiepileptic drug withdrawal and long-term seizure outcome after paediatric epilepsy surgery (TimeToStop): a retrospective observational study. Lancet Neurol 11:784–791. https://doi.org/10.1016/S1474-4422(12)70165-5 CrossRefPubMed

55.

Lee SY, Lee JY, Kim DW et al (2008) Factors related to successful antiepileptic drug withdrawal after anterior temporal lobectomy for medial temporal lobe epilepsy. Seizure 17:11–18. https://doi.org/10.1016/j.seizure.2007.05.014 CrossRefPubMed

56.

Janszky J, Janszky I, Schulz R et al (2005) Temporal lobe epilepsy with hippocampal sclerosis: predictors for long-term surgical outcome. Brain 128:395–404. https://doi.org/10.1093/brain/awh358 CrossRefPubMed

57.

Englot DJ, Chang EF (2014) Rates and predictors of seizure freedom in resective epilepsy surgery: an update. Neurosurg Rev 37:389–404. https://doi.org/10.1007/s10143-014-0527-9 (discussion 404–5) CrossRefPubMedPubMedCentral

58.

Grivas A, Schramm J, Kral T et al (2006) Surgical treatment for refractory temporal lobe epilepsy in the elderly: seizure outcome and neuropsychological sequels compared with a younger cohort. Epilepsia 47:1364–1372. https://doi.org/10.1111/j.1528-1167.2006.00608.x CrossRefPubMed

59.

Lee YJ, Lee JS (2013) Temporal lobe epilepsy surgery in children versus adults: from etiologies to outcomes. Korean J Pediatr 56:275–281. https://doi.org/10.3345/kjp.2013.56.7.275 CrossRefPubMedPubMedCentral

60.

Tonini C, Beghi E, Berg AT et al (2004) Predictors of epilepsy surgery outcome: a meta-analysis. Epilepsy Res 62:75–87. https://doi.org/10.1016/j.eplepsyres.2004.08.006 CrossRefPubMed

61.

Radhakrishnan K, So EL, Silbert PL et al (1998) Predictors of outcome of anterior temporal lobectomy for intractable epilepsy: a multivariate study. Neurology 51:465–471CrossRefPubMed

62.

Schmeiser B, Zentner J, Steinhoff BJ et al (2017) The role of presurgical EEG parameters and of reoperation for seizure outcome in temporal lobe epilepsy. Seizure 51:174–179. https://doi.org/10.1016/j.seizure.2017.08.015 CrossRefPubMed

63.

Grote A, Witt JA, Surges R et al (2015) A second chance-reoperation in patients with failed surgery for intractable epilepsy: long-term outcome, neuropsychology and complications. J Neurol Neurosurg Psychiatry. https://doi.org/10.1136/jnnp-2015-310322 PubMed

Titel: Does early postoperative drug regimen impact seizure control in patients undergoing temporal lobe resections?
verfasst von: Barbara Schmeiser
Bernhard J. Steinhoff
Andreas Schulze-Bonhage
Publikationsdatum: 06.01.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Neurology / Ausgabe 3/2018
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-017-8700-z

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Objective

Patients and methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2018

The long-term impact of early treatment of multiple sclerosis on the risk of disability pension

Risk factors in Swedish young men for amyotrophic lateral sclerosis in adulthood

Distinct manifestation of cognitive deficits associate with different resting-state network disruptions in non-demented patients with Parkinson’s disease

Cognitive phenotypes in multiple sclerosis

Genotype–phenotype correlation and frequency of distribution in a cohort of Chinese Charcot–Marie–Tooth patients associated with GDAP1 mutations